Acebutolol
Acebutolol may decrease the bronchodilatory activities of Isoetarine.
Acepromazine
Acepromazine may decrease the vasoconstricting activities of Isoetarine.
Alfuzosin
Alfuzosin may decrease the vasoconstricting activities of Isoetarine.
Advertisement
Alprenolol
Alprenolol may decrease the bronchodilatory activities of Isoetarine.
Amineptin
The risk or severity of adverse effects can be increased when Amineptine is combined with Isoetarine.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Isoetarine.
Advertisement
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Isoetarine.
Amphetamine
The risk or severity of adverse effects can be increased when Amphetamine is combined with Isoetarine.
Aripiprazole
Aripiprazole may decrease the vasoconstricting activities of Isoetarine.
Advertisement
Asenapine
Asenapine may decrease the vasoconstricting activities of Isoetarine.
Atenolol
Atenolol may decrease the bronchodilatory activities of Isoetarine.
Atomoxetine
Atomoxetine may increase the tachycardic activities of Isoetarine.
Atosiban
The risk or severity of adverse effects can be increased when Isoetarine is combined with Atosiban.
Azosemide
Isoetarine may increase the hypokalemic activities of Azosemide.
Bendroflumethiazide
Isoetarine may increase the hypokalemic activities of Bendroflumethiazide.
Benzthiazide
Isoetarine may increase the hypokalemic activities of Benzthiazide.
Benzylpenicilloyl polylysine
Isoetarine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
BETAHISTINE
The therapeutic efficacy of Isoetarine can be decreased when used in combination with Betahistine.
Betaxolol
Betaxolol may decrease the bronchodilatory activities of Isoetarine.
Bisoprolol
Bisoprolol may decrease the bronchodilatory activities of Isoetarine.
Bopindolol
Bopindolol may decrease the bronchodilatory activities of Isoetarine.
Brexpiprazole
Brexpiprazole may decrease the vasoconstricting activities of Isoetarine.
Bromocriptine
Bromocriptine may increase the hypertensive and vasoconstricting activities of Isoetarine.
Bumetanide
Isoetarine may increase the hypokalemic activities of Bumetanide.
Bunazosin
Bunazosin may decrease the vasoconstricting activities of Isoetarine.
Bupranolol
Bupranolol may decrease the bronchodilatory activities of Isoetarine.
Butriptyline
The risk or severity of adverse effects can be increased when Butriptyline is combined with Isoetarine.
Cabergoline
Cabergoline may increase the hypertensive and vasoconstricting activities of Isoetarine.
Carteolol
Carteolol may decrease the bronchodilatory activities of Isoetarine.
Carvedilol
Carvedilol may decrease the vasoconstricting activities of Isoetarine.
Celiprolol
Celiprolol may decrease the bronchodilatory activities of Isoetarine.
Chlorothiazide
Isoetarine may increase the hypokalemic activities of Chlorothiazide.
Chlorpromazine
Chlorpromazine may decrease the vasoconstricting activities of Isoetarine.
Chlorthalidone
Isoetarine may increase the hypokalemic activities of Chlorthalidone.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Isoetarine.
Clozapine
Clozapine may decrease the vasoconstricting activities of Isoetarine.
Cyclopenthiazide
Isoetarine may increase the hypokalemic activities of Cyclopenthiazide.
Dapiprazole
Dapiprazole may decrease the vasoconstricting activities of Isoetarine.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Isoetarine.
Desvenlafaxine
Desvenlafaxine may increase the tachycardic activities of Isoetarine.
Dextroamphetamine
Dextroamphetamine may decrease the vasoconstricting activities of Isoetarine.
Dihydroergotamine
Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Isoetarine.
Dothiepin
The risk or severity of adverse effects can be increased when Dosulepin is combined with Isoetarine.
Doxazosin
Doxazosin may decrease the vasoconstricting activities of Isoetarine.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Isoetarine.
Dronedarone
Dronedarone may decrease the vasoconstricting activities of Isoetarine.
Droperidol
Droperidol may decrease the vasoconstricting activities of Isoetarine.
Duloxetine
Duloxetine may increase the tachycardic activities of Isoetarine.
Epinephrine
Epinephrine may decrease the vasoconstricting activities of Isoetarine.
ergoloid mesylates, USP
Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Isoetarine.
Ergonovine
Ergonovine may increase the hypertensive and vasoconstricting activities of Isoetarine.
Ergotamine
Ergotamine may increase the hypertensive and vasoconstricting activities of Isoetarine.
Escitalopram
Escitalopram may decrease the vasoconstricting activities of Isoetarine.
Esmolol
Esmolol may decrease the bronchodilatory activities of Isoetarine.
Ethacrynate
Isoetarine may increase the hypokalemic activities of Etacrynic acid.
Ethacrynic Acid
Isoetarine may increase the hypokalemic activities of Etacrynic acid.
Flupenthixol
Flupentixol may decrease the vasoconstricting activities of Isoetarine.
Furazolidone
The risk or severity of adverse effects can be increased when Furazolidone is combined with Isoetarine.
Furosemide
Isoetarine may increase the hypokalemic activities of Furosemide.
Hydrochlorothiazide
Isoetarine may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Isoetarine may increase the hypokalemic activities of Hydroflumethiazide.
Iloperidone
Iloperidone may decrease the vasoconstricting activities of Isoetarine.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Isoetarine.
Indapamide
Isoetarine may increase the hypokalemic activities of Indapamide.
Indoramin
Indoramin may decrease the vasoconstricting activities of Isoetarine.
Iproniazid
The risk or severity of adverse effects can be increased when Iproniazid is combined with Isoetarine.
Isocarboxazid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isoetarine.
Labetalol
Labetalol may decrease the vasoconstricting activities of Isoetarine.
Levomilnacipran
Levomilnacipran may increase the tachycardic activities of Isoetarine.
Lisdexamfetamine
Lisdexamfetamine may decrease the vasoconstricting activities of Isoetarine.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may decrease the vasoconstricting activities of Isoetarine.
MELITRACEN
The risk or severity of adverse effects can be increased when Melitracen is combined with Isoetarine.
Mepindolol
Mepindolol may decrease the bronchodilatory activities of Isoetarine.
Methotrimeprazine
Methotrimeprazine may decrease the vasoconstricting activities of Isoetarine.
Methyclothiazide
Isoetarine may increase the hypokalemic activities of Methyclothiazide.
Methylene blue
The risk or severity of adverse effects can be increased when Methylene blue is combined with Isoetarine.
Methylergonovine
Methylergometrine may increase the hypertensive and vasoconstricting activities of Isoetarine.
Metolazone
Isoetarine may increase the hypokalemic activities of Metolazone.
Metoprolol
Metoprolol may decrease the bronchodilatory activities of Isoetarine.
Milnacipran
Milnacipran may increase the tachycardic activities of Isoetarine.
Minaprine
The risk or severity of adverse effects can be increased when Minaprine is combined with Isoetarine.
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Isoetarine.
Nadolol
Nadolol may decrease the bronchodilatory activities of Isoetarine.
Nebivolol
Nebivolol may decrease the bronchodilatory activities of Isoetarine.
Nefazodone
Nefazodone may decrease the vasoconstricting activities of Isoetarine.
Nialamide
The risk or severity of adverse effects can be increased when Nialamide is combined with Isoetarine.
Nicardipine
Nicardipine may decrease the vasoconstricting activities of Isoetarine.
Nicergoline
Nicergoline may decrease the vasoconstricting activities of Isoetarine.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Isoetarine.
Olanzapine
Olanzapine may decrease the vasoconstricting activities of Isoetarine.
Opipramol
The risk or severity of adverse effects can be increased when Opipramol is combined with Isoetarine.
Oxprenolol
Oxprenolol may decrease the bronchodilatory activities of Isoetarine.
Paliperidone
Paliperidone may decrease the vasoconstricting activities of Isoetarine.
Pargyline
The risk or severity of adverse effects can be increased when Pargyline is combined with Isoetarine.
Penbutolol
Penbutolol may decrease the bronchodilatory activities of Isoetarine.
Periciazine
Propericiazine may decrease the vasoconstricting activities of Isoetarine.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Isoetarine.
Phenoxybenzamine
Phenoxybenzamine may decrease the vasoconstricting activities of Isoetarine.
Phentolamine
Phentolamine may decrease the vasoconstricting activities of Isoetarine.
Phentolamine Mesylate
Phentolamine may decrease the vasoconstricting activities of Isoetarine.
Pindolol
Pindolol may decrease the bronchodilatory activities of Isoetarine.
Piretanide
Isoetarine may increase the hypokalemic activities of Piretanide.
Pizotyline
Pizotifen may decrease the vasoconstricting activities of Isoetarine.
Polythiazide
Isoetarine may increase the hypokalemic activities of Polythiazide.
Prazosin
Prazosin may decrease the vasoconstricting activities of Isoetarine.
Procaine
The risk or severity of adverse effects can be increased when Procaine is combined with Isoetarine.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Isoetarine.
Promazine
Promazine may decrease the vasoconstricting activities of Isoetarine.
Propiomazine
Propiomazine may decrease the vasoconstricting activities of Isoetarine.
Propiverine
Propiverine may decrease the vasoconstricting activities of Isoetarine.
Propranolol
Propranolol may decrease the bronchodilatory activities of Isoetarine.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Isoetarine.
Quetiapine
Quetiapine may decrease the vasoconstricting activities of Isoetarine.
Quetiapine fumarate
Quetiapine may decrease the vasoconstricting activities of Isoetarine.
Quinethazone
Isoetarine may increase the hypokalemic activities of Quinethazone.
Quinidine
Quinidine may decrease the vasoconstricting activities of Isoetarine.
Racepinephrine
Racepinephrine may decrease the vasoconstricting activities of Isoetarine.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Isoetarine.
Risperidone
Risperidone may decrease the vasoconstricting activities of Isoetarine.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Isoetarine.
Silodosin
Silodosin may decrease the vasoconstricting activities of Isoetarine.
Sotalol
Sotalol may decrease the bronchodilatory activities of Isoetarine.
Spironolactone
Spironolactone may decrease the vasoconstricting activities of Isoetarine.
Tamsulosin
Tamsulosin may decrease the vasoconstricting activities of Isoetarine.
Terazosin
Terazosin may decrease the vasoconstricting activities of Isoetarine.
Tertatolol
Tertatolol may decrease the bronchodilatory activities of Isoetarine.
Thioproperazine
Thioproperazine may decrease the vasoconstricting activities of Isoetarine.
Thioridazine
Thioridazine may decrease the vasoconstricting activities of Isoetarine.
Tianeptine
The risk or severity of adverse effects can be increased when Tianeptine is combined with Isoetarine.
Timolol
Timolol may decrease the bronchodilatory activities of Isoetarine.
Timolol Anhydrous
Timolol may decrease the bronchodilatory activities of Isoetarine.
Tolazoline
Tolazoline may decrease the vasoconstricting activities of Isoetarine.
Toloxatone
The risk or severity of adverse effects can be increased when Toloxatone is combined with Isoetarine.
Torsemide
Isoetarine may increase the hypokalemic activities of Torasemide.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Isoetarine.
Trazodone
Trazodone may decrease the vasoconstricting activities of Isoetarine.
Trichlormethiazide
Isoetarine may increase the hypokalemic activities of Trichlormethiazide.
Trifluoperazine
Trifluoperazine may decrease the vasoconstricting activities of Isoetarine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Isoetarine.
Urapidil
Urapidil may decrease the vasoconstricting activities of Isoetarine.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Isoetarine.
Venlafaxine
Venlafaxine may increase the tachycardic activities of Isoetarine.
Verapamil
Verapamil may decrease the vasoconstricting activities of Isoetarine.
Ziprasidone
Ziprasidone may decrease the vasoconstricting activities of Isoetarine.
Zuclopenthixol
Zuclopenthixol may decrease the vasoconstricting activities of Isoetarine.
